Katherine Breward is an Associate Professor at the University of Winnipeg and an award-winning case writer. Her research focuses primarily on disability accommodation in the workplace and labor market entry for historically disadvantaged populations. Her research has appeared in the Canadian Journal of Disability Studies; Case Research Journal; Equality, Diversity and Inclusion: An International Journal; and the Journal of Immigrant and Minority Health.
Katherine Breward
From this contributor
Providing accommodations for autistic workers benefits everyone
Companies can use many strategies to make workplaces more inclusive.
Providing accommodations for autistic workers benefits everyone
Explore more from The Transmitter
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.